173 related articles for article (PubMed ID: 29064628)
1. Off-label prescriptions and decisions on reimbursement requests in Germany - a retrospective analysis.
Seidenschnur KEK; Dressler C; Weller K; Nast A; Werner RN
J Dtsch Dermatol Ges; 2017 Nov; 15(11):1103-1109. PubMed ID: 29064628
[TBL] [Abstract][Full Text] [Related]
2. [Off-label therapy in rheumatology].
Krüger K; Sieper J
Z Rheumatol; 2012 Feb; 71(2):99-100. PubMed ID: 22370799
[No Abstract] [Full Text] [Related]
3. [Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].
Janzen RW; Ludwig WD;
Z Rheumatol; 2012 Feb; 71(2):108-10, 112-8. PubMed ID: 22370801
[TBL] [Abstract][Full Text] [Related]
4. [Off-label therapy from the perspective of the medical insurance service].
Grell L; Rieger M
Z Rheumatol; 2012 Feb; 71(2):101-4, 106-7. PubMed ID: 22370800
[TBL] [Abstract][Full Text] [Related]
5. [Appropriate off-label prescription in practice].
Augustin M
Hautarzt; 2013 Oct; 64(10):728-35. PubMed ID: 24150820
[TBL] [Abstract][Full Text] [Related]
6. Impact of off-label use regulations on patient care in dermatology - a prospective study of cost-coverage applications filed by tertiary dermatology clinics throughout Germany.
Werner RN; Pennitz A; Eisert L; Schmidle P; Zink A; Abraham S; Schäkel K; Wolff I; Goebeler M; Plange J; Sollfrank L; Zielbauer S; Koll P; Amschler K; Müller V; Nast A
J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2241-2249. PubMed ID: 35737866
[TBL] [Abstract][Full Text] [Related]
7. Japanese regulatory system for approval of off-label drug use: evaluation of safety and effectiveness in literature-based applications.
Shimazawa R; Ikeda M
Clin Ther; 2012 Oct; 34(10):2104-16. PubMed ID: 23036337
[TBL] [Abstract][Full Text] [Related]
8. [Off-label use and G-BA. Legal framework for off-label use].
Brucklacher U; Brockmeyer NH; Riedel C
Hautarzt; 2013 Oct; 64(10):736-42. PubMed ID: 24150821
[TBL] [Abstract][Full Text] [Related]
9. [2 - Plausibility evaluations and fee recoveries in radiology].
Harney A; Remmert J
Rofo; 2014 Dec; 186(12):1158-62. PubMed ID: 25423107
[No Abstract] [Full Text] [Related]
10. [Even with sensory aids there is a regress risk].
MMW Fortschr Med; 2015 Oct; 157(18):27. PubMed ID: 26985492
[No Abstract] [Full Text] [Related]
11. [Off-label use of drugs--the legal framework].
Koyuncu A
Dtsch Med Wochenschr; 2012 Jul; 137(30):1519-23. PubMed ID: 22869512
[No Abstract] [Full Text] [Related]
12. [Claims over 600,000 euro. Compromise with recourse hydra].
Schlingensiepen I
MMW Fortschr Med; 2014 Apr; 156(7):10-1. PubMed ID: 24956636
[No Abstract] [Full Text] [Related]
13. [EBM 2000 plus: KBV announces further changes].
Schmidt K
MMW Fortschr Med; 2005 May; 147(20):44-5. PubMed ID: 15957860
[No Abstract] [Full Text] [Related]
14. [Public financing for off-label use of drugs].
Hammerman A; Lipschitz Y; Pliskin J; Greenberg D
Harefuah; 2011 Feb; 150(2):163-7, 204. PubMed ID: 22164947
[TBL] [Abstract][Full Text] [Related]
15. [Regress for expensive medicines? When costly therapies are not a problem].
Nitz G
MMW Fortschr Med; 2013 Feb; 155(3):12. PubMed ID: 23573755
[No Abstract] [Full Text] [Related]
16. ["With all suitable means". Off-label-use and public statutory employers' liability insurance].
Skudlik C; Lindemann B; Woltjen M; Brandenburg S; John SM
Hautarzt; 2013 Oct; 64(10):743-7. PubMed ID: 24150822
[TBL] [Abstract][Full Text] [Related]
17. [Financial settlement relevant regulation in transfer of patients].
Baberg HT; de Zeeuw J
Med Klin (Munich); 2005 Jun; 100(6):365. PubMed ID: 15968490
[No Abstract] [Full Text] [Related]
18. [EBM 2010. Starting 1 July budgets must be considered]].
Walbert H
MMW Fortschr Med; 2010 Apr; 152(17):11. PubMed ID: 20509250
[No Abstract] [Full Text] [Related]
19. [Regional electro-hyperthermia--technical principles, clinical results and health insurance aspects].
Heyll U
Versicherungsmedizin; 2012 Jun; 64(2):70-3. PubMed ID: 22808643
[TBL] [Abstract][Full Text] [Related]
20. [Key points of reform of the German health service 2003+. From the viewpoint of the Society of Private Practice Accounting Services].
Urologe A; 2003 Jan; 42(1):136-8. PubMed ID: 14655650
[No Abstract] [Full Text] [Related]
[Next] [New Search]
